HCW Biologics (HCWB) Change in Cash (2020 - 2025)

HCW Biologics (HCWB) has 6 years of Change in Cash data on file, last reported at $855555.0 in Q4 2025.

• Quarterly Change in Cash fell 76.73% year-over-year to $855555.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$2.7 million (down 352.17% YoY) and the FY2025 annual result came in at -$2.7 million, down 352.17% from the prior year.
• Change in Cash improved to $855555.0 in Q4 2025, from -$1.3 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $10.8 million in Q3 2022 to a low of -$10.9 million in Q2 2023.
• A 5-year average of -$325168.5 and a median of -$1.5 million in 2021 frame the typical range for Change in Cash.
• Annual changes were most pronounced in 2022 — Change in Cash soared 499.23% — and 2025, when it tumbled 829.48%.
• Tracing HCWB's Change in Cash over 5 years: stood at -$3.4 million in 2021, then decreased by 14.83% to -$3.9 million in 2022, then plunged by 95.64% to -$7.6 million in 2023, then jumped by 148.21% to $3.7 million in 2024, then plunged by 76.73% to $855555.0 in 2025.
• The last three Change in Cash figures came in at $855555.0 (Q4 2025), -$1.3 million (Q3 2025), and $1.3 million (Q2 2025), per Business Quant data.